Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries - Wikidata - awgldk - TriplyDB

Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries

Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries

http://www.wikidata.org/entity/Q36218239

about

PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology MRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): When to acquire and how to interpret.Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque.Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques Non-invasive imaging of atherosclerosis High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics.Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis.NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.Molecular imaging of inflammation in atherosclerosis.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18)F-FDG PET and vascular inflammation: time to refine the paradigm?Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging Towards coronary plaque imaging using simultaneous PET-MR: a simulation study.High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability.Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.Relationship between particulate matter exposure and atherogenic profile in "Ground Zero" workers as shown by dynamic contrast enhanced MR imaging.Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.Feasibility of carotid artery PET/MRI in psoriasis patients Biological imaging of atherosclerosis: moving beyond anatomy The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.Vascular imaging with positron emission tomography.Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.Clot composition and treatment approach to acute ischemic stroke: The road so far.PET imaging of inflammation in atherosclerosis.PET imaging of atherosclerosis.Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.Imaging the event-prone coronary artery plaque.Imaging atherosclerosis with positron emission tomography.Imaging Atherosclerotic Plaque Calcification: Translating Biology.SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.

P2860

Q26750798-A5C9FD79-BC02-4B56-A54A-BD677752D198 Q26766542-B4559C3B-BC95-493C-B730-60C0F74DE307 Q26769824-44F8D885-63FF-4BE2-804D-608E7B5E485B Q26781838-9DF9797B-BFC9-4A74-BCA8-6E8EE21929AF Q26992143-088532AC-53FD-479E-ACA7-EF16162DAB2A Q30355172-B965D93E-9CD7-4734-BE6C-A3A3F22FFD6A Q30414631-53B8E698-3AFF-4CBD-9097-97EFA5A81E57 Q30416517-5A2BEF9D-56B2-4701-A085-4E5CA2782810 Q30418403-D0C83160-9F7B-4536-ABE7-B6874BCBAA84 Q30430958-0823EB7B-45BC-4E9B-AC74-1C330EC6378E Q30436195-E2FE4B62-5089-4230-A088-235BD9E45ADE Q30446268-7959D425-3168-461D-B592-E472CE47A103 Q33586616-D5A7AFA7-26E1-417E-AD65-15F37F65F8CD Q33624365-EEECDF80-8E02-46CB-84D0-C9977668766E Q33624371-01A11944-A43C-421B-AEBF-E1D6D7E8992A Q33719962-9680952F-2867-40F3-B8BD-36229D8A9FEB Q34694001-2A77273C-FD31-4081-A0C2-C7DD52FA5F37 Q35072987-719BDB07-8199-4471-A454-FACF5B462FB6 Q35099168-6D1CC877-9FB9-4782-AD16-F75EBECB55BA Q35577419-EB8BEA46-ECBD-4FE9-ACF8-B55E0B2ADACC Q36434865-4B081A99-4AD9-4E48-B9B7-68E1CCE098BD Q36824109-0F0780B6-6CCA-4AB4-A76F-1DDB9B77B379 Q37025668-064FBC35-D142-4485-A9B3-10B38B4AC89C Q37082503-07EFD80C-7007-4E0E-A7BD-DA4442875A0A Q37215507-86D4B6EF-6926-44D5-B77B-1855548842A5 Q37228234-E077A356-4DC8-4226-B8BB-775BD59E4D88 Q37296851-726B95F3-FDAA-401E-8E4F-46A4A512B582 Q37832982-970FB123-D00C-4305-8135-400ED9F104A4 Q37868709-25D81CBB-500A-4ECF-ABB7-82A66E06A691 Q38052020-72C89EA1-47D9-4C02-AF64-F35EE494C90F Q38171472-7B661E59-00E4-42FC-A269-76FA6A84B09E Q38218902-FC0D9C33-8DBC-4FAC-9508-1E872A34CEBC Q38326673-09A1263C-4521-4658-8522-0AEBEE24D3AD Q38397910-BA0D2001-6670-4D1E-87CB-8F69F9C171C8 Q38661565-65C386D4-A439-461A-ACFE-926883183F18 Q38820272-9CC66AB2-528E-4EEC-8CAF-7E1C685CA239 Q38875478-D8E9A06E-4195-4065-B8EC-C421FE407DC8 Q41238952-D2E13425-37C2-47D1-B153-E42A09DF322F Q42701584-CFE7803F-9F55-4F6C-AA76-ADBC640527FF Q43142797-57D031FF-D3B0-4B69-8CC7-3B340B438F06

P2860

Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries

http://www.wikidata.org/entity/Q36218239

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Multimodality imaging of ather ...... n carotid and femoral arteries

@ast

Multimodality imaging of ather ...... n carotid and femoral arteries

@en

type

label

Multimodality imaging of ather ...... n carotid and femoral arteries

@ast

Multimodality imaging of ather ...... n carotid and femoral arteries

@en

prefLabel

Multimodality imaging of ather ...... n carotid and femoral arteries

@ast

Multimodality imaging of ather ...... n carotid and femoral arteries

@en

P1433

Q36218239-6CC3304D-DCF4-46BD-829C-69FE755D1FAF

P1476

Q36218239-0F9E3A43-7B31-464F-B9EF-2D3DF8D1E3C4

P2093

Q36218239-043D7214-FFE3-415B-9F43-24EB69AC0B3C

Q36218239-3900735C-9D56-4309-B027-0EF1F3A405AB

Q36218239-88B7C085-A222-466F-A40D-24160B3BA9EC

Q36218239-9BC022D1-AF46-4904-B1B9-BC9B8B400D48

Q36218239-F6678046-250F-4EA5-A886-EF6588D96C15

P2860

Q36218239-006283AB-CFBB-4996-A3EB-84F5E482CD80

Q36218239-05C2FE05-761A-4ED0-AB1E-427F18872D9F

Q36218239-15FA7814-9567-496A-A491-F09B2E165861

Q36218239-493092B8-5095-4B54-A809-38A30B8690D5

Q36218239-514D70BA-5C86-45AD-98A6-7609EE76212A

Q36218239-61849104-2E45-4F58-B296-D9069FAC4DDB

Q36218239-73DA9924-722C-4809-87EA-C68D879AEFCA

Q36218239-7631026E-1064-44BA-9BAA-E185D26C72BA

Q36218239-810A93DC-94E3-46FA-94DA-0FA1EAE049B9

Q36218239-8469F82F-89E9-45E5-876B-12E51E80DD9E

P304

Q36218239-ED529491-6792-4D93-820E-201431B12B6A

P31

Q36218239-3358371B-2DD2-4261-8AE8-17162E454071

P356

Q36218239-6ED248F0-0704-4785-BE18-A40394804824

P433

Q36218239-4D71E4C4-413C-4769-BED5-D669C4F4B3CB

P478

Q36218239-37145951-FAA6-42F1-9349-D6CC1736E6ED

P50

Q36218239-8AE71326-7C47-4405-8C9D-C8EA1ABDD1EB

Q36218239-B3924528-0DA8-4B2D-A700-CC437F4E74A3

Q36218239-F00E840E-4447-4862-862F-B9348CDCC9D0

P577

Q36218239-20799493-B1BA-4E08-A911-DC67397C7C2D

P5875

Q36218239-02DD4832-C937-4E10-9415-BBA56E7C3986

P698

Q36218239-6B0ADE86-A9E3-4386-AA29-5FD5779191BC

P921

Q36218239-D7D78C9C-DD3F-4122-81B1-B40C09E605B3

P932

Q36218239-53D32C86-6E3C-4D14-891D-41B021FD8E1A

P356

J.ATHEROSCLEROSIS.2009.04.023

P1433

Atherosclerosis

P1476

Multimodality imaging of ather ...... n carotid and femoral arteries

@en

P2093

Hamza El Aidi

http://www.w3.org/2001/XMLSchema#string

Lingde Yang

http://www.w3.org/2001/XMLSchema#string

Michael Farkouh

http://www.w3.org/2001/XMLSchema#string

Stephane S Silvera

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.

From 2D PET to 3D PET: issues of data representation and image reconstruction.

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Pathophysiology of calcium deposition in coronary arteries.

Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Pathologic assessment of the vulnerable human coronary plaque.

P304

139-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2009.04.023

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

207

http://www.w3.org/2001/XMLSchema#string

P50

Valentín Fuster Carulla

P577

2009-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26239200

http://www.w3.org/2001/XMLSchema#string

P698

19467659

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3436906

http://www.w3.org/2001/XMLSchema#string